Stock Activity: Concho Resources (NYSE:CXO), Travelzoo (NASDAQ:TZOO), ContraVir Pharmaceuticals (NASDAQ:CTRV), Guidance Software (NASDAQ:GUID)

AMC Entertainment Holdings, Inc. (NYSE:AMC) shares decreased -1.74% in last trading session and ended the day at $28.88. AMC Gross Margin is 61.00% and its has a return on assets of 2.30%. AMC Entertainment Holdings, Inc. (NYSE:AMC) quarterly performance is 26.13%.

AMC Entertainment Holdings, Inc. (NYSE:AMC) said that, its proposed $1.1-billion acquisition of Carmike Cinemas is the latest deal to significantly extend the Hollywood influence of China’s richest man, Wang Jianlin.

Concho Resources, Inc. (NYSE:CXO) ended the last trading day at $102.50. Company weekly volatility is calculated as 3.79% and price to cash ratio as 58.00. Concho Resources, Inc. (NYSE:CXO) showed a weekly performance of 7.39%.

On 3 March, Concho Resources, Inc. (NYSE:CXO) reported a positive outcome from an important drug-drug interaction study regarding the Company’s novel antiviral drug candidate FV-100, which is currently in Phase 3 clinical development to prevent the debilitating shingles-associated pain known as post-herpetic neuralgia (PHN).

On 15 March, Travelzoo Inc. (NASDAQ:TZOO) shares decreased -2.21% and was closed at $7.98. TZOO EPS growth in last 5 year was -1.50%. Travelzoo Inc. (NASDAQ:TZOO) year to date (YTD) performance is -4.66%.

Travelzoo Inc. (NASDAQ:TZOO) had its target price cut by Macquarie from $11.25 to $8.75 in a research report released on Tuesday morning, MarketBeat Ratings reports. They currently have a neutral rating on the stock.

ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) shares decreased -5.61% in last trading session and ended the day at $1.01. CTRV has a return on assets of -380.60%. ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) quarterly performance is -37.65%.

On 3 March, ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) reported a positive outcome from an important drug-drug interaction study regarding the Company’s novel antiviral drug candidate FV-100, which is currently in Phase 3 clinical development to prevent the debilitating shingles-associated pain known as post-herpetic neuralgia (PHN).

Guidance Software, Inc. (NASDAQ:GUID) caters to the Technology space. It has a net profit margin of -13.50% and weekly performance is -12.08%. On the last day of trading company shares ended up at $4.66. Guidance Software, Inc. (NASDAQ:GUID) distance from 50-day simple moving average (SMA50) is 4.46%.

Guidance Software, Inc. (NASDAQ:GUID) said that, it will present 28th Annual ROTH Conference to be held March 13-16, 2016 at the Ritz Carlton Hotel in Orange County, California. Guidance is scheduled to present at 9:30 a.m. PT on Monday, March 14th.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *